Skip to main content
LABU logo
LABU
(NYSEARCA)
Direxion Daily S&P Biotech Bull 3X ETF
$253.77-- (--)
Loading... - Market loading

LABU ETF: Direxion Daily S&P Biotech Bull 3X ETF - Price, Holdings & Analysis

Direxion Daily S&P Biotech Bull 3X ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$239.61 - $259.00
52-Week High$333.00
52-Week Low$58.35
Open$243.96
Volume231.10K
Average Volume (3M)533.00K
Assets (AUM)539.72M
Expense Ratio0.96%
Total Holdings166
Inception DateMay 27, 2015
1 Day Change0.04%
1 Month Change2.31%
6 Month Change40.62%
YTD Change61.12%
1 Year Change288.50%
52-Week Change277.97%
5 Year Change-78.64%
10 Year Change-65.49%
50-Day MA$223.28
200-Day MA$174.39
RSI48.95
Stochastic %K15.16
Stochastic %D19.15
Annual Dividend$1.12
Dividend Yield0.44%
Last Dividend Ex-DateApr 1, 2026
Dividend Growth YoY243.56%
Years Dividend Growth1

Frequently Asked Questions About Direxion Daily S&P Biotech Bull 3X ETF

What is the current price of LABU?

The latest LABU price is $253.77. The 52-week range is $58.35–$333.00. LABU has returned 278.0% over the past 52 weeks.

What is the expense ratio for LABU?

LABU's annual expense ratio is 0.96%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does LABU pay dividends?

Yes, LABU pays a 0.44% dividend yield. The last ex-dividend date was 2026-04-01. View full dividend history in the Dividends section.

What are the top holdings of LABU?

LABU's largest holdings are Revolution Medicines, Inc (1.3%), Travere Therapeutics, Inc. (1.3%), TG Therapeutics, Inc. (1.3%) (combined weight: 3.9%). The fund holds 166 total positions. View the complete portfolio breakdown in the Holdings section.

How does LABU compare to similar ETFs?

Compare LABU (0.96% expense ratio, $540M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.